← brief for 2026-08-26 · Slowing decline

Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP

Key takeaways

A new trial will compare an experimental IV drug (Anruikefen) to the standard oral medicine (nalfurafine) for sleep problems caused by itchy skin in hemodialysis patients. There are no results yet—the study is just beginning to enroll participants.

Who did this work

Run by Zhujiang Hospital.
Sites: Zhujiang Hospital, Southern Medical University, No. 253 Gongye Road, Guangzhou, 510282, China

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-08-25
https://clinicaltrials.gov/study/NCT07380113